京東集團(09618.HK)旗下京東產發獲約8億美元融資 由高瓴及華平等領投
京東集團(09618.HK)(JD.US)公布,旗下京東智能產業發展(京東產發)已與聯席領投的投資人高瓴投資、華平投資及其他投資人簽訂不可贖回B輪優先股融資的最終協議,籌資總額預計約8億美元。
交易完成後,京東仍是京東產發的大股東,預計此次融資將有助於京東產發業務擴張及模式轉型,並可進一步加強其基礎設施物業管理能力。
京東產發為京東集團旗下提供基礎設施資產管理與綜合服務的子集團。於去年3月,京東產發完成A輪優先股融資,規模為7億美元,領投方同為高瓴和華平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.